Once-Weekly #Insulin for Type 2 #Diabetes without Previous Insulin Treatment
It is thought that a reduction in the frequency of basal insulin injections might facilitate treatment acceptance and adherence among patients with type 2 diabetes. Insulin icodec is a basal insulin analogue designed for once-weekly administration that is in development for the treatment of diabetes We conducted a 26-week, randomized, double-blind, double-dummy, phase 2 trial to investigate the efficacy and safety of once-weekly insulin icodec … Continue reading Once-Weekly #Insulin for Type 2 #Diabetes without Previous Insulin Treatment